Helicobacter pylori vaccine development and use: A cost-effectiveness analysis using the institute of medicine methodology

Helicobacter

Volumn 4, Issue 4, 1999, Pages 272-280

  Rupnow, Marcia F T ^a,d   Owens, Douglas K ^b,c   Shachter, Ross ^a   Parsonnet, Julie ^c  

^a STANFORD UNIVERSITY   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Health Research and Policy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; ECONOMICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; INFANT; MIDDLE AGED; ORGANIZATION; PEPTIC ULCER; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; STOMACH TUMOR; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGED; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INSTITUTE OF MEDICINE (U.S.); MIDDLE AGED; PEPTIC ULCER; STOMACH NEOPLASMS; UNITED STATES; VACCINATION;

EID: 0033257824     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.1999.99311.x     Document Type: Article

References (20)

1. Taylor DN, Parsonnet J. Epidemiology and natural history of Helicobacter pylori infection. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the Gastrointestinal Tract. New York: Raven Press, 1995:551-63.
2. Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trials. Lancet 1996;348:150-4.
3. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Infection with Helicobacter pylori. In: Schistosomes, Liver Flukes and Helicobacter pylori. Lyon: IARC, 1994:177-240.
4. Blum AL. Helicobacter pylori and peptic ulcer disease. Scand J Gastroenterol 1996;214 (suppl 3): S24-7.
5. Axon AT. Eradication of Helicobacter pylori. Scand J Gastroenterol 1996;214 (suppl 4):S47-53.
6. World Health Organization. Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press, 1996.
7. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-27.
8. Sandier RS. Gastric cancer. In: Everhart JE, ed. Digestive Diseases in the United States: Epidemiology and Impact. Washington, DC: US Government Printing Office, 1994:181-204.
9. World Health Organization. Global Health Statistics: A Compendium of Incidence, Prevalence, and Mortality Estimates for over 200 Conditions. Cambridge, MA: Harvard University Press, 1996.
10. Kurata JH, Honda GD, Frankl H. The incidence of duodenal and gastric ulcers in a large health maintenance organization. Am J Public Health 1985;75:625-9.
11. Sonnenberg A. Peptic ulcer. In: Everhart JE, ed. Digestive Diseases in the United States: Epidemiol-ogy and Impact. Washington, DC: US Government Printing Office, 1994:357-408.
12. Pisani P, Parkin DM, Muñoz N, Ferlay J. Cancer and infection: Estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997;6:387-400.
13. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997;24:2-17.
14. Parsonnet J. Helicobacter pylori: The size of the problem. Gut 1998;43 (suppl 1):S6-9.
15. Institute of Medicine. New Vaccine Development: Establishing Priorities: Vol. I. Diseases of Importance in the United States. Washington, DC: National Academy Press, 1985.
16. Institute of Medicine. New Vaccine Development: Establishing Priorities. Vol. II. Diseases of Importance in Developing Countries. Washington, DC: National Academy Press, 1986.
17. Owens DK, Sanders GD, Harris RA, et al. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med 1997;126:1-12.
18. Bureau of the Census. Statistical Abstract of the United States; 115th ed. Washington, DC: US Government Printing Office, 1995.
19. US Office of Management and Budget. Budget of the United States Government - Fiscal Year 2000, 1999. http://www.access.gop.gov/usbudget/fy2000/pdf/hist.pdf.
20. World Health Organization. WHO Cancer Mortality Databank, 1998. http:/WWW-DEP.IARC.FR/dataava/globocan/who.htm.